Compare FOUR & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOUR | FMC |
|---|---|---|
| Founded | 1999 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | 2020 | N/A |
| Metric | FOUR | FMC |
|---|---|---|
| Price | $64.02 | $13.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 13 |
| Target Price | ★ $100.32 | $24.08 |
| AVG Volume (30 Days) | 1.6M | ★ 4.7M |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | ★ 14.66 | N/A |
| EPS | ★ 2.15 | N/A |
| Revenue | ★ $3,878,400,000.00 | $3,608,400,000.00 |
| Revenue This Year | $29.56 | N/A |
| Revenue Next Year | $24.08 | $0.86 |
| P/E Ratio | $29.82 | ★ N/A |
| Revenue Growth | ★ 23.16 | N/A |
| 52 Week Low | $61.23 | $12.17 |
| 52 Week High | $127.50 | $57.00 |
| Indicator | FOUR | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 34.93 | 36.16 |
| Support Level | $66.09 | $12.85 |
| Resistance Level | $67.63 | $14.15 |
| Average True Range (ATR) | 2.46 | 0.62 |
| MACD | -0.34 | 0.43 |
| Stochastic Oscillator | 4.85 | 33.55 |
Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.